SUPERNUS PHARMACEUTICALS, INC. (SUPN) › EPS (Diluted)SUPERNUS PHARMACEUTICALS, INC. (SUPN) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2012: $-2.722013: $-2.902014: $-0.262015: $0.282016: $1.762017: $1.082018: $2.052019: $2.102020: $2.362021: $0.982022: $1.042023: $0.022024: $1.322025: $-0.68$-0.682012EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-0.68-151.5%2024$1.32+6500.0%2023$0.02-98.1%2022$1.04+6.1%2021$0.98-58.5%2020$2.36+12.4%2019$2.10+2.4%2018$2.05+89.8%2017$1.08-38.6%2016$1.76+528.6%2015$0.28+207.7%2014$-0.26+91.0%2013$-2.90-6.6%2012$-2.72—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share